CoChat

Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c‐jun and JNK

Open access
Lu, Liang‐Huei, Lee, Shoei‐Sheng, Huang, Huei‐Chen · 1998 · British Journal of Pharmacology
Cited by 56

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The mechanisms of the antiproliferative effect of epigallocatechin, one of the catechin derivatives found in green tea, in vascular smooth muscle cells were studied. The proliferative response was determined from the uptake of tritiated thymidine. In the concentration range of 10−6 to 10−4 m, catechin, epicatechin, epigallocatechin, epicatechin gallate and epigallocatechin, epigallocatechin gallate, concentration‐dependently inhibited the proliferative response stimulated by serum in rabbit cultured vascular smooth muscle cells. Catechin and epicatechin were less effective in inhibiting the serum‐stimulated smooth muscle cell proliferation, indicating that the galloyl group may be important for full inhibitory activity. Epigallocatechin (EGC) inhibited the proliferative responses in different cells including rat aortic smooth muscle cells (A7r5 cells), rabbit cultured aortic smooth muscle cells, human coronary artery smooth muscle cells, and human CEM lymphocytes in a concentration‐dependent manner. The possible mechanisms of the antiproliferative effect of EGC were further studied in A7r5 cells. The membranous protein tyrosine kinase activity stimulated by serum in A7r5 cells was significantly reduced by 10−5 m EGC. In contrast, the cytosolic protein kinase C activity stimulated by phorbol ester was unaffected by directly incubating with EGC (10−6−10−4 m). We also performed Western blot analysis using the anti‐phosphotyrosine monoclonal antibody PY‐20. EGC (10−5 m) reduced the levels of tyrosine phosphorylated proteins with different molecular weights, indicating that EGC may inhibit the protein tyrosine kinase activity or stimulate the protein phosphatase activity. Reverse transcription‐polymerase chain reaction analysis of c‐fos, c‐jun and c‐myc mRNA levels demonstrated that c‐jun mRNA level after serum‐stimulation was significantly reduced by 10−5 m EGC. However, the reduction of c‐fos and c‐myc mRNA levels by 10−5 m EGC did not achieve significance. Western blot analysis using the antibody against JNK (c‐jun N‐terminal kinase) and ERK (extracellular signal‐regulated kinase) demonstrated that the level of phosphorylated JNK1, but not phosphorylated ERK1 and ERK2, was reduced by 10−5 m EGC. Direct measurement of kinase activity by immune complex kinase assay confirmed that JNK1 activity was inhibited by EGC treatment. These results demonstrate that EGC preferentially reduced the activation of JNK/SAPK (stress‐activated protein kinase) signal transduction pathway. It is suggested that the antiproliferative effect of epigallocatechin on vascular smooth muscle cells may partly be mediated through inhibition of protein tyrosine kinase activity, reducing c‐jun mRNA expression and inhibiting JNK1 activation. Tea catechins may be useful as a template for the development of drugs to prevent the pathological changes of atherosclerosis and post‐angioplasty restenosis. British Journal of Pharmacology (1998) 124, 1227–1237; doi:10.1038/sj.bjp.0701912

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0701912

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Lu, L., Lee, S., & Huang, H.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1998-07
Volume
124
Issue
6
Pages
1227-1237
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2076868456
Cited by
56
References
4
FWCI
3.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.